Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04681209 · ClinicalTrials.gov registry record · NA
Increasing Children's Defending Behaviors: Using Deviance Regulation
A NA study, sponsored by Auburn University.
- Completed
- Registry status
- NA
- Development phase
- 1,564
- Enrollment target
NCT04681209: Completed NA study, sponsored by Auburn University.
NCT04681209 is a NA study that has completed, run by Auburn University. The registered enrollment target is 1,564 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (11% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04681209, a NA study, has completed, sponsored by Auburn University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,564 participants
- Enrollment target
Study Summary
The National Institute of Child Health and Human Development (NICHD) has identified bullying as a significant public health concern. The research tests a novel approach to increase children's defending of victims of bullying. Previous research has shown that the presence of defenders leads to decreases in bullying. Thus, promoting defending has become a critical component of anti-bullying interventions. However, how to best motivate defending has been relatively unstudied. Deviance Regulation Theory (DRT) provides a theoretical basis for motivating positive health and social behaviors. This theory proposes that individuals are motivated to behave in ways that differentiate them from others in a positive manner. Accordingly, individuals will be motivated to engage in a behavior if they believe the behavior occurs infrequently and will be viewed positively by others. As children report that few of their peers defend victims of bullying, the goal of this study is to increase defending by communicating to children that defenders possess traits valued by their peers (e.g., being popular, kind). Children in 4th-grade and 5th-grade classrooms received a DRT-based anti-bullying intervention or an anti-bullying intervention focused on increasing empathy for victims and strategies for defending peers. Data collection occurred three times during the school year: a) at baseline, two weeks prior to the intervention; b) 3 months post-intervention; and c) 6 months post-intervention. Findings showed that compared to the traditional anti-bullying intervention, the DRT-based intervention resulted in larger, more sustained gains in teacher-reported defending, but not peer-reported or self-reported defending. Contrary to expectations, gains in teacher-reported defending were greatest for children who viewed defending to be normative amongst their classmates. Increases in defending were also greatest among those children least likely to defend (i.e., those low in popularity and prosocia
Primary Outcome
Peer ratings of how often each participating classmate defended bullied peers
Interventions
- BEHAVIORAL DRT Condition
- BEHAVIORAL Empathy Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,564 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2020-07-30 |
| Phase | NA |
What the finished NCT04681209 record still lists
NCT04681209 is an interventional study that assigns participants to a tested intervention. Its 1,564 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (11% higher).
The record links to 0 conditions, and to 2 interventions - of which DRT Condition is the first listed.
NCT04681209 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04681209 about?
NCT04681209 is a clinical study titled "Increasing Children's Defending Behaviors: Using Deviance Regulation". The National Institute of Child Health and Human Development (NICHD) has identified bullying as a significant public health concern. The research tests a novel approach to increase children's defending of victims of bullying. Previous research has shown that the presence of defenders leads to decrea...
What is the current status of trial NCT04681209?
This trial is currently completed. It is a NA study. The enrollment target is 1,564 participants. The study started on 2017-09-01. Estimated completion is 2020-07-30.
What interventions are being tested in trial NCT04681209?
The interventions under investigation include: DRT Condition (BEHAVIORAL), Empathy Condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT04681209?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04681209's enrollment target sits among peer trials
1,564 64th of 2000 higher than 1,937 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06034080 · 1,566 participants · NA
Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections
- NCT06881069 · 1,560 participants · NA
Reach Through Equitable Implementation in Utah
- NCT06445946 · 1,572 participants · Phase 4
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI